Home

Emily M. Leproust

CIK 1753655 · Chief Executive Officer · last filed 2026-08-27

Emily M. Leproust is a Chief Executive Officer who has filed 217 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider sold $6.3M of TWST on Aug 27, 2026. Across all open-market trades the lifetime net is −$107.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $102.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$102.61M

Companies

4

Total Filings

217

Lifetime Open-Market Net

-$107.46M

Filer Profile

Reported Address
C/O TWIST BIOSCIENCE CORPORATION
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TWST Chief Executive Officer 805,566 $124.72 $100.47M -$107.46M 149 2026-08-27
WGS Director 24,852 $85.99 $2.14M $0 1 2026-06-23
GeneDx Holdings Corp. (WGSWW) Delisted Director 21,276 $0.00 $4 $0 5 2025-06-23
GeneDx Holdings Corp. (SMFRW) Delisted Director 37,836 $0.02 $908 $0 5 2022-05-12

Recent Filings

217 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-27 TWST Sell (S) −41,570 -$6.32M EDGAR
2026-08-25 TWST Notice (144) −41,570 -$6.32M EDGAR
2026-08-25 TWST Sell (S) −6,639 -$923.3K EDGAR
2026-08-21 TWST Notice (144) −6,639 -$923.3K EDGAR
2026-08-14 TWST Mixed — -$1.96M EDGAR
2026-08-12 TWST Notice (144) −19,952 -$2.50M EDGAR
2026-08-12 TWST Mixed — -$11.16M EDGAR
2026-08-10 TWST Notice (144) −113,318 -$14.18M EDGAR
2026-08-05 TWST Sell (S) −5,101 -$435.2K EDGAR
2026-08-03 TWST Notice (144) −5,101 -$435.2K EDGAR
Showing 1–10 of 217
Page 1 of 22
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.